| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 30 | 2020 | 1490 | 2.200 |
Why?
|
| Photochemotherapy | 22 | 2004 | 823 | 2.080 |
Why?
|
| Carotid Stenosis | 23 | 2020 | 860 | 1.940 |
Why?
|
| Endarterectomy, Carotid | 19 | 2023 | 555 | 1.710 |
Why?
|
| Blood Vessel Prosthesis Implantation | 22 | 2022 | 1427 | 1.520 |
Why?
|
| Tunica Intima | 14 | 2011 | 458 | 1.500 |
Why?
|
| Ischemia | 17 | 2018 | 1877 | 1.450 |
Why?
|
| Carotid Body Tumor | 4 | 2020 | 34 | 1.210 |
Why?
|
| Blood Vessel Prosthesis | 21 | 2022 | 954 | 1.140 |
Why?
|
| Aortic Aneurysm, Abdominal | 24 | 2022 | 1228 | 1.140 |
Why?
|
| Angioplasty, Balloon | 14 | 2011 | 588 | 1.090 |
Why?
|
| Arterial Occlusive Diseases | 13 | 2010 | 748 | 1.000 |
Why?
|
| Carotid Artery, Internal | 6 | 2018 | 445 | 0.970 |
Why?
|
| Lower Extremity | 6 | 2012 | 1201 | 0.940 |
Why?
|
| Endovascular Procedures | 11 | 2022 | 2181 | 0.910 |
Why?
|
| Intermittent Claudication | 7 | 2012 | 304 | 0.890 |
Why?
|
| Muscle, Smooth, Vascular | 10 | 2004 | 1491 | 0.770 |
Why?
|
| Stents | 20 | 2021 | 3179 | 0.760 |
Why?
|
| Femoral Artery | 14 | 2009 | 827 | 0.740 |
Why?
|
| Leg | 11 | 2012 | 1089 | 0.700 |
Why?
|
| Carotid Arteries | 11 | 2020 | 941 | 0.650 |
Why?
|
| Aorta, Abdominal | 18 | 2003 | 625 | 0.630 |
Why?
|
| Popliteal Artery | 4 | 2009 | 310 | 0.580 |
Why?
|
| Peripheral Vascular Diseases | 5 | 2010 | 488 | 0.570 |
Why?
|
| Iliac Artery | 9 | 2011 | 343 | 0.570 |
Why?
|
| Hyperplasia | 19 | 2011 | 1152 | 0.550 |
Why?
|
| Postoperative Complications | 36 | 2021 | 15650 | 0.530 |
Why?
|
| Prosthesis Failure | 3 | 2012 | 1204 | 0.520 |
Why?
|
| Photosensitizing Agents | 9 | 2002 | 623 | 0.510 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2015 | 321 | 0.510 |
Why?
|
| Specialties, Surgical | 1 | 2019 | 389 | 0.490 |
Why?
|
| Peripheral Arterial Disease | 5 | 2020 | 1272 | 0.480 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2015 | 231 | 0.470 |
Why?
|
| Extracellular Matrix | 6 | 2004 | 1725 | 0.470 |
Why?
|
| Catheterization | 5 | 2011 | 1432 | 0.420 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2009 | 537 | 0.420 |
Why?
|
| Aorta, Thoracic | 4 | 2014 | 1096 | 0.410 |
Why?
|
| Organometallic Compounds | 9 | 2000 | 647 | 0.390 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2015 | 1351 | 0.390 |
Why?
|
| Wounds, Penetrating | 1 | 2014 | 313 | 0.380 |
Why?
|
| Aneurysm | 3 | 2010 | 337 | 0.380 |
Why?
|
| Thrombosis | 5 | 2011 | 2942 | 0.380 |
Why?
|
| Time Factors | 47 | 2021 | 39975 | 0.370 |
Why?
|
| Urinary Retention | 2 | 2023 | 106 | 0.370 |
Why?
|
| Transplantation Tolerance | 4 | 2018 | 605 | 0.360 |
Why?
|
| Carotid Artery Diseases | 7 | 2020 | 877 | 0.350 |
Why?
|
| Vascular Patency | 13 | 2012 | 910 | 0.350 |
Why?
|
| Treatment Outcome | 57 | 2023 | 64651 | 0.350 |
Why?
|
| Aortic Aneurysm, Thoracic | 8 | 2019 | 696 | 0.340 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2010 | 148 | 0.340 |
Why?
|
| Laser Therapy | 10 | 2002 | 1092 | 0.340 |
Why?
|
| Risk Assessment | 23 | 2021 | 23990 | 0.340 |
Why?
|
| Vena Cava Filters | 1 | 2012 | 261 | 0.330 |
Why?
|
| Thrombectomy | 2 | 2010 | 705 | 0.330 |
Why?
|
| Patient Care Team | 1 | 2020 | 2523 | 0.330 |
Why?
|
| Saphenous Vein | 4 | 2009 | 516 | 0.330 |
Why?
|
| Limb Salvage | 8 | 2013 | 481 | 0.320 |
Why?
|
| Aneurysm, Infected | 1 | 2009 | 81 | 0.320 |
Why?
|
| Angioplasty | 5 | 2016 | 354 | 0.320 |
Why?
|
| Graft Rejection | 8 | 2018 | 4445 | 0.320 |
Why?
|
| Major Histocompatibility Complex | 4 | 2015 | 927 | 0.320 |
Why?
|
| Kaplan-Meier Estimate | 19 | 2017 | 6479 | 0.310 |
Why?
|
| Blood Coagulation Disorders | 2 | 2010 | 350 | 0.310 |
Why?
|
| Crowns | 1 | 2009 | 155 | 0.310 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 1784 | 0.310 |
Why?
|
| Renal Artery Obstruction | 7 | 2012 | 219 | 0.300 |
Why?
|
| Heart Transplantation | 7 | 2018 | 3234 | 0.300 |
Why?
|
| Prosthesis Implantation | 1 | 2012 | 592 | 0.300 |
Why?
|
| Streptococcus agalactiae | 1 | 2009 | 337 | 0.290 |
Why?
|
| Indoles | 9 | 2000 | 1832 | 0.280 |
Why?
|
| Renal Artery | 9 | 2012 | 351 | 0.280 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 1999 | 591 | 0.280 |
Why?
|
| Brachial Artery | 2 | 2002 | 366 | 0.280 |
Why?
|
| Anticoagulants | 3 | 2011 | 4813 | 0.280 |
Why?
|
| Aged | 94 | 2022 | 169235 | 0.280 |
Why?
|
| Blood Vessels | 3 | 2002 | 1113 | 0.270 |
Why?
|
| Swine, Miniature | 7 | 2018 | 961 | 0.270 |
Why?
|
| Arteriosclerosis | 10 | 2004 | 1055 | 0.270 |
Why?
|
| Histocompatibility | 3 | 2015 | 317 | 0.260 |
Why?
|
| Flow Cytometry | 2 | 2015 | 5868 | 0.260 |
Why?
|
| Retrospective Studies | 54 | 2023 | 80582 | 0.260 |
Why?
|
| Specialization | 2 | 2020 | 779 | 0.250 |
Why?
|
| Endarterectomy | 8 | 2009 | 196 | 0.250 |
Why?
|
| Risk Factors | 41 | 2022 | 74167 | 0.240 |
Why?
|
| Cattle | 9 | 2004 | 3848 | 0.240 |
Why?
|
| Aortic Aneurysm | 7 | 2021 | 648 | 0.240 |
Why?
|
| Jugular Veins | 2 | 2004 | 210 | 0.240 |
Why?
|
| Hemoglobinometry | 1 | 2004 | 35 | 0.240 |
Why?
|
| Health Status Indicators | 1 | 2010 | 970 | 0.230 |
Why?
|
| Heparin | 1 | 2011 | 1632 | 0.230 |
Why?
|
| Endoleak | 2 | 2021 | 111 | 0.230 |
Why?
|
| Cells, Cultured | 14 | 2015 | 18964 | 0.220 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 1179 | 0.220 |
Why?
|
| Deferoxamine | 1 | 2004 | 154 | 0.220 |
Why?
|
| Swine | 9 | 2018 | 5914 | 0.220 |
Why?
|
| Free Radical Scavengers | 1 | 2004 | 211 | 0.210 |
Why?
|
| Thrombomodulin | 1 | 2003 | 105 | 0.210 |
Why?
|
| Oxyhemoglobins | 1 | 2004 | 211 | 0.210 |
Why?
|
| Male | 107 | 2023 | 360736 | 0.210 |
Why?
|
| Lasers | 4 | 2001 | 951 | 0.210 |
Why?
|
| Lung Transplantation | 3 | 2018 | 1309 | 0.210 |
Why?
|
| Stem Cells | 1 | 2015 | 3522 | 0.210 |
Why?
|
| Gamma Rays | 2 | 2004 | 318 | 0.200 |
Why?
|
| Odds Ratio | 13 | 2017 | 9645 | 0.200 |
Why?
|
| Carotid Artery Injuries | 2 | 2000 | 96 | 0.200 |
Why?
|
| Aged, 80 and over | 44 | 2021 | 58956 | 0.200 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2004 | 829 | 0.200 |
Why?
|
| Survival Rate | 18 | 2016 | 12720 | 0.200 |
Why?
|
| Stroke | 12 | 2020 | 9756 | 0.200 |
Why?
|
| Humans | 137 | 2023 | 761423 | 0.200 |
Why?
|
| Aortic Diseases | 7 | 2014 | 735 | 0.200 |
Why?
|
| Female | 98 | 2022 | 392581 | 0.200 |
Why?
|
| Radiation-Sensitizing Agents | 5 | 1997 | 350 | 0.200 |
Why?
|
| Spectrum Analysis | 1 | 2004 | 451 | 0.200 |
Why?
|
| Thromboplastin | 1 | 2003 | 286 | 0.200 |
Why?
|
| Organ Preservation | 2 | 2015 | 382 | 0.190 |
Why?
|
| Hypertension, Renovascular | 3 | 2012 | 116 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2004 | 8179 | 0.190 |
Why?
|
| Reoperation | 10 | 2013 | 4303 | 0.180 |
Why?
|
| Cell Adhesion | 3 | 2004 | 3087 | 0.180 |
Why?
|
| Patient Selection | 11 | 2013 | 4244 | 0.180 |
Why?
|
| Carotid Artery, Common | 3 | 2016 | 175 | 0.180 |
Why?
|
| Embolic Protection Devices | 1 | 2020 | 42 | 0.180 |
Why?
|
| Perfusion | 3 | 2015 | 1373 | 0.180 |
Why?
|
| Proportional Hazards Models | 15 | 2021 | 12456 | 0.180 |
Why?
|
| Middle Aged | 66 | 2021 | 220826 | 0.170 |
Why?
|
| Rats | 20 | 2004 | 23742 | 0.170 |
Why?
|
| Sterilization | 1 | 2001 | 133 | 0.170 |
Why?
|
| Methylene Blue | 1 | 2000 | 155 | 0.170 |
Why?
|
| Blood Substitutes | 1 | 2000 | 57 | 0.170 |
Why?
|
| Graft Survival | 6 | 2018 | 3819 | 0.170 |
Why?
|
| Monitoring, Intraoperative | 5 | 2012 | 942 | 0.170 |
Why?
|
| Endothelium, Vascular | 3 | 2003 | 4430 | 0.170 |
Why?
|
| Venous Thromboembolism | 1 | 2012 | 1866 | 0.160 |
Why?
|
| Art | 1 | 2019 | 64 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 2 | 1997 | 1960 | 0.160 |
Why?
|
| Porphyrins | 2 | 1999 | 352 | 0.160 |
Why?
|
| Indium Radioisotopes | 2 | 1989 | 113 | 0.160 |
Why?
|
| Arm | 1 | 2002 | 590 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Duplex | 5 | 2016 | 198 | 0.160 |
Why?
|
| Brain Ischemia | 3 | 2018 | 3049 | 0.160 |
Why?
|
| Angiography | 10 | 2017 | 1599 | 0.160 |
Why?
|
| Animals | 46 | 2018 | 168441 | 0.160 |
Why?
|
| Intracellular Membranes | 1 | 1999 | 389 | 0.150 |
Why?
|
| Hypotension | 2 | 2023 | 879 | 0.150 |
Why?
|
| Carotenoids | 3 | 1991 | 621 | 0.150 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2009 | 92 | 0.150 |
Why?
|
| Coronary Restenosis | 1 | 2001 | 396 | 0.150 |
Why?
|
| Predictive Value of Tests | 8 | 2015 | 15262 | 0.150 |
Why?
|
| Prosthesis Design | 6 | 2022 | 2115 | 0.150 |
Why?
|
| Hemoglobins | 2 | 2004 | 1524 | 0.150 |
Why?
|
| Cerebral Revascularization | 1 | 2020 | 259 | 0.150 |
Why?
|
| Kidney Transplantation | 4 | 2018 | 4234 | 0.140 |
Why?
|
| Vocal Cord Paralysis | 1 | 2020 | 272 | 0.140 |
Why?
|
| Staphylococcal Infections | 2 | 2001 | 1407 | 0.140 |
Why?
|
| Registries | 5 | 2020 | 8223 | 0.130 |
Why?
|
| Immune Tolerance | 2 | 2015 | 2300 | 0.130 |
Why?
|
| Logistic Models | 12 | 2021 | 13255 | 0.130 |
Why?
|
| Radiography | 9 | 2014 | 6966 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2016 | 2243 | 0.130 |
Why?
|
| Lipids | 2 | 2005 | 3340 | 0.130 |
Why?
|
| Tunica Media | 2 | 2011 | 112 | 0.130 |
Why?
|
| Fascia | 1 | 1996 | 140 | 0.130 |
Why?
|
| Aortic Rupture | 10 | 2021 | 319 | 0.130 |
Why?
|
| Cell Division | 7 | 1999 | 4466 | 0.130 |
Why?
|
| Databases as Topic | 4 | 2011 | 473 | 0.130 |
Why?
|
| Aluminum | 5 | 1997 | 152 | 0.130 |
Why?
|
| Prosthesis-Related Infections | 1 | 2001 | 488 | 0.120 |
Why?
|
| Muscle Weakness | 1 | 2018 | 412 | 0.120 |
Why?
|
| Arteries | 5 | 1994 | 1124 | 0.120 |
Why?
|
| Reperfusion Injury | 3 | 2008 | 1023 | 0.120 |
Why?
|
| Hindlimb | 3 | 2013 | 513 | 0.120 |
Why?
|
| Embolism | 2 | 2018 | 400 | 0.120 |
Why?
|
| Chi-Square Distribution | 7 | 2017 | 3418 | 0.120 |
Why?
|
| Boston | 9 | 2016 | 9330 | 0.120 |
Why?
|
| Muscle, Skeletal | 4 | 2018 | 4946 | 0.120 |
Why?
|
| Brain Death | 1 | 2018 | 357 | 0.120 |
Why?
|
| Severity of Illness Index | 12 | 2018 | 15838 | 0.120 |
Why?
|
| Histocompatibility Antigens | 1 | 2015 | 467 | 0.110 |
Why?
|
| Vasa Vasorum | 1 | 2013 | 25 | 0.110 |
Why?
|
| Neurosurgery | 1 | 2020 | 679 | 0.110 |
Why?
|
| Muscle Strength | 1 | 2018 | 624 | 0.110 |
Why?
|
| Clinical Competence | 2 | 2019 | 4793 | 0.110 |
Why?
|
| Fibromuscular Dysplasia | 1 | 1994 | 55 | 0.110 |
Why?
|
| Propensity Score | 3 | 2019 | 1908 | 0.110 |
Why?
|
| Pericardiocentesis | 1 | 2014 | 78 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 18247 | 0.110 |
Why?
|
| Angioscopy | 1 | 1993 | 47 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2018 | 3244 | 0.110 |
Why?
|
| Blood Platelets | 2 | 2002 | 2481 | 0.110 |
Why?
|
| Diverticulum | 1 | 2014 | 137 | 0.110 |
Why?
|
| Follow-Up Studies | 20 | 2017 | 39117 | 0.110 |
Why?
|
| Diabetes Complications | 2 | 2010 | 1315 | 0.110 |
Why?
|
| Blood Transfusion | 1 | 2000 | 1299 | 0.110 |
Why?
|
| Intraoperative Complications | 4 | 2010 | 1165 | 0.100 |
Why?
|
| Skin Transplantation | 2 | 2015 | 1083 | 0.100 |
Why?
|
| Veins | 3 | 1996 | 768 | 0.100 |
Why?
|
| Inguinal Canal | 1 | 2012 | 71 | 0.100 |
Why?
|
| Recurrence | 8 | 2014 | 8469 | 0.100 |
Why?
|
| Age Factors | 4 | 2020 | 18400 | 0.100 |
Why?
|
| Free Radicals | 3 | 1997 | 238 | 0.100 |
Why?
|
| Asymptomatic Diseases | 4 | 2018 | 587 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 5 | 2018 | 1432 | 0.100 |
Why?
|
| Spinal Cord Ischemia | 2 | 2011 | 94 | 0.100 |
Why?
|
| Kidney | 4 | 2015 | 7049 | 0.100 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 12058 | 0.100 |
Why?
|
| Reference Standards | 1 | 2015 | 1004 | 0.100 |
Why?
|
| Diabetic Foot | 1 | 2016 | 380 | 0.100 |
Why?
|
| Platelet Factor 4 | 1 | 2011 | 129 | 0.100 |
Why?
|
| Heart | 2 | 2015 | 4405 | 0.100 |
Why?
|
| Cranial Nerve Injuries | 1 | 2010 | 28 | 0.090 |
Why?
|
| Aortography | 3 | 2010 | 420 | 0.090 |
Why?
|
| Neointima | 1 | 2011 | 133 | 0.090 |
Why?
|
| Fingers | 1 | 1994 | 507 | 0.090 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2011 | 283 | 0.090 |
Why?
|
| Motor Cortex | 1 | 2018 | 1006 | 0.090 |
Why?
|
| Ureteral Obstruction | 1 | 2012 | 293 | 0.090 |
Why?
|
| Tissue Donors | 3 | 2018 | 2331 | 0.090 |
Why?
|
| Gallium Radioisotopes | 1 | 1991 | 195 | 0.090 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 539 | 0.090 |
Why?
|
| Dissection | 1 | 1992 | 298 | 0.090 |
Why?
|
| Hypoglossal Nerve Diseases | 1 | 2010 | 8 | 0.090 |
Why?
|
| Iliac Aneurysm | 2 | 2000 | 37 | 0.090 |
Why?
|
| Leadership | 1 | 2019 | 1385 | 0.090 |
Why?
|
| Embolization, Therapeutic | 4 | 2008 | 1418 | 0.090 |
Why?
|
| Chronic Disease | 5 | 2012 | 9320 | 0.090 |
Why?
|
| Skin | 1 | 2004 | 4481 | 0.090 |
Why?
|
| Cryopreservation | 1 | 2015 | 728 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 2 | 2011 | 1792 | 0.090 |
Why?
|
| Constriction, Pathologic | 3 | 2004 | 1097 | 0.090 |
Why?
|
| Phototherapy | 1 | 1993 | 368 | 0.090 |
Why?
|
| Apoptosis | 4 | 2015 | 9488 | 0.090 |
Why?
|
| Focal Infection | 1 | 1989 | 9 | 0.090 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1991 | 223 | 0.080 |
Why?
|
| Renal Insufficiency | 4 | 2012 | 809 | 0.080 |
Why?
|
| Forecasting | 2 | 2017 | 2928 | 0.080 |
Why?
|
| Surgical Wound Infection | 3 | 2001 | 1525 | 0.080 |
Why?
|
| Polyamines | 3 | 1986 | 133 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 2072 | 0.080 |
Why?
|
| Anastomosis, Surgical | 5 | 1996 | 982 | 0.080 |
Why?
|
| Incidence | 7 | 2020 | 21341 | 0.080 |
Why?
|
| Drug Substitution | 1 | 2011 | 290 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2012 | 20556 | 0.080 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2010 | 134 | 0.080 |
Why?
|
| Cell Movement | 4 | 2004 | 5203 | 0.080 |
Why?
|
| Back Pain | 1 | 2012 | 545 | 0.080 |
Why?
|
| Retreatment | 2 | 2021 | 598 | 0.080 |
Why?
|
| Paraganglioma | 1 | 2010 | 142 | 0.080 |
Why?
|
| Analysis of Variance | 6 | 2005 | 6231 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 3356 | 0.080 |
Why?
|
| Models, Animal | 3 | 2015 | 2113 | 0.080 |
Why?
|
| Risk Adjustment | 1 | 2012 | 600 | 0.070 |
Why?
|
| Cardiovascular Agents | 1 | 2014 | 840 | 0.070 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 1989 | 138 | 0.070 |
Why?
|
| Celiac Artery | 1 | 2008 | 65 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2018 | 1530 | 0.070 |
Why?
|
| Device Removal | 1 | 2012 | 630 | 0.070 |
Why?
|
| Surgical Flaps | 1 | 1996 | 1671 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 696 | 0.070 |
Why?
|
| Databases, Factual | 4 | 2020 | 7956 | 0.070 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 1443 | 0.070 |
Why?
|
| Leukocytes | 1 | 2015 | 2028 | 0.070 |
Why?
|
| Combined Modality Therapy | 3 | 2016 | 8529 | 0.070 |
Why?
|
| Culture Media, Conditioned | 2 | 1999 | 522 | 0.070 |
Why?
|
| Immunoglobulin G | 2 | 1989 | 4549 | 0.070 |
Why?
|
| Splenic Artery | 1 | 2007 | 57 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2000 | 3810 | 0.070 |
Why?
|
| Decision Support Techniques | 2 | 2013 | 1998 | 0.070 |
Why?
|
| Ornithine Decarboxylase | 1 | 1986 | 63 | 0.070 |
Why?
|
| Mesentery | 1 | 2007 | 202 | 0.070 |
Why?
|
| Intestinal Polyps | 1 | 1986 | 104 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2012 | 1071 | 0.070 |
Why?
|
| Staphylococcus epidermidis | 2 | 2001 | 123 | 0.060 |
Why?
|
| Renal Dialysis | 3 | 2012 | 1797 | 0.060 |
Why?
|
| Enoxaparin | 1 | 2008 | 391 | 0.060 |
Why?
|
| Shock, Cardiogenic | 1 | 1991 | 709 | 0.060 |
Why?
|
| Groin | 1 | 2005 | 106 | 0.060 |
Why?
|
| Electroencephalography | 4 | 2017 | 6224 | 0.060 |
Why?
|
| Lung | 2 | 2015 | 9995 | 0.060 |
Why?
|
| Phenanthrenes | 1 | 2005 | 66 | 0.060 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2005 | 50 | 0.060 |
Why?
|
| Length of Stay | 5 | 2023 | 6422 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 1989 | 622 | 0.060 |
Why?
|
| Duodenum | 1 | 2008 | 489 | 0.060 |
Why?
|
| Random Allocation | 2 | 2000 | 2394 | 0.060 |
Why?
|
| Constriction | 3 | 2012 | 171 | 0.060 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3687 | 0.060 |
Why?
|
| Prognosis | 6 | 2021 | 29620 | 0.060 |
Why?
|
| Probability | 1 | 2009 | 2478 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2851 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2927 | 0.060 |
Why?
|
| Antibodies | 1 | 2011 | 2421 | 0.060 |
Why?
|
| Durable Medical Equipment | 1 | 2003 | 23 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2012 | 2760 | 0.050 |
Why?
|
| Endothelin-1 | 2 | 2015 | 302 | 0.050 |
Why?
|
| Photochemistry | 1 | 2003 | 239 | 0.050 |
Why?
|
| Hypertension | 1 | 2023 | 8542 | 0.050 |
Why?
|
| Critical Illness | 3 | 2011 | 2723 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 1991 | 1393 | 0.050 |
Why?
|
| Aorta | 4 | 1997 | 2041 | 0.050 |
Why?
|
| Radionuclide Imaging | 4 | 1992 | 1975 | 0.050 |
Why?
|
| Mastectomy, Radical | 1 | 2002 | 19 | 0.050 |
Why?
|
| Hyperemia | 1 | 2004 | 221 | 0.050 |
Why?
|
| Running | 1 | 2007 | 488 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 1987 | 520 | 0.050 |
Why?
|
| Aneurysm, Ruptured | 1 | 2008 | 463 | 0.050 |
Why?
|
| Kidney Function Tests | 3 | 2012 | 678 | 0.050 |
Why?
|
| Photobiology | 1 | 2002 | 10 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9277 | 0.050 |
Why?
|
| Disease-Free Survival | 4 | 2016 | 6814 | 0.050 |
Why?
|
| Cytokines | 2 | 2018 | 7392 | 0.050 |
Why?
|
| Endoscopy | 2 | 2000 | 1851 | 0.050 |
Why?
|
| United States | 8 | 2016 | 72339 | 0.050 |
Why?
|
| Coronary Disease | 4 | 1996 | 5919 | 0.050 |
Why?
|
| Adult | 28 | 2021 | 221148 | 0.050 |
Why?
|
| Calcinosis | 2 | 2003 | 1469 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 685 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2001 | 6395 | 0.050 |
Why?
|
| Disability Evaluation | 2 | 2018 | 1836 | 0.050 |
Why?
|
| Pancreas | 1 | 2008 | 1690 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2020 | 2751 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2000 | 66 | 0.050 |
Why?
|
| Versicans | 1 | 2000 | 40 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2000 | 215 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 1984 | 2016 | 0.040 |
Why?
|
| Elastic Tissue | 1 | 2000 | 65 | 0.040 |
Why?
|
| beta Carotene | 3 | 1991 | 523 | 0.040 |
Why?
|
| Postoperative Period | 2 | 2004 | 1815 | 0.040 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2000 | 141 | 0.040 |
Why?
|
| Ankle Brachial Index | 2 | 2011 | 163 | 0.040 |
Why?
|
| Colonic Neoplasms | 3 | 1986 | 2538 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2000 | 283 | 0.040 |
Why?
|
| Procollagen | 1 | 2000 | 187 | 0.040 |
Why?
|
| Extremities | 2 | 2004 | 867 | 0.040 |
Why?
|
| Fibrosis | 3 | 2007 | 2048 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 613 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 20093 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 5492 | 0.040 |
Why?
|
| Pulsatile Flow | 2 | 2014 | 321 | 0.040 |
Why?
|
| Transplantation, Homologous | 2 | 2000 | 4808 | 0.040 |
Why?
|
| Atherosclerosis | 2 | 2013 | 3407 | 0.040 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2020 | 143 | 0.040 |
Why?
|
| Microcirculation | 1 | 2004 | 1273 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2012 | 3243 | 0.040 |
Why?
|
| Urinary Catheterization | 1 | 2020 | 193 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2010 | 2092 | 0.040 |
Why?
|
| Massachusetts | 2 | 2017 | 8832 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 981 | 0.040 |
Why?
|
| Medicare | 2 | 2016 | 6770 | 0.040 |
Why?
|
| Blood Flow Velocity | 3 | 2014 | 1371 | 0.040 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 1989 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2002 | 890 | 0.040 |
Why?
|
| Actuarial Analysis | 3 | 2006 | 374 | 0.040 |
Why?
|
| Urodynamics | 1 | 2020 | 346 | 0.040 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 2023 | 0.040 |
Why?
|
| Lectins | 1 | 2000 | 491 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2002 | 673 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1970 | 0.040 |
Why?
|
| Premedication | 2 | 1989 | 247 | 0.040 |
Why?
|
| Intraoperative Care | 3 | 2005 | 766 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2006 | 2010 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 1986 | 6339 | 0.040 |
Why?
|
| Intestines | 2 | 2021 | 1909 | 0.040 |
Why?
|
| Acute Disease | 3 | 2021 | 7238 | 0.040 |
Why?
|
| Immunosuppressive Agents | 3 | 2015 | 4172 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2018 | 362 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 3 | 2014 | 882 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2020 | 590 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2005 | 1174 | 0.040 |
Why?
|
| Rectal Neoplasms | 1 | 1986 | 1157 | 0.040 |
Why?
|
| Hospitals, Private | 2 | 2009 | 63 | 0.040 |
Why?
|
| Growth Substances | 1 | 1999 | 768 | 0.040 |
Why?
|
| Inflammation | 4 | 2013 | 10762 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1999 | 618 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2009 | 7409 | 0.040 |
Why?
|
| Injections, Intralesional | 1 | 1998 | 277 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2000 | 803 | 0.030 |
Why?
|
| Myocardial Revascularization | 1 | 2001 | 792 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2000 | 584 | 0.030 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1996 | 50 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2000 | 487 | 0.030 |
Why?
|
| Fibrinolytic Agents | 2 | 2018 | 2084 | 0.030 |
Why?
|
| Mesenteric Arteries | 2 | 2001 | 178 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 2189 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2004 | 1403 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 1900 | 0.030 |
Why?
|
| Rats, Inbred Strains | 4 | 1992 | 2089 | 0.030 |
Why?
|
| Rats, Inbred ACI | 1 | 1995 | 34 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2012 | 10203 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2000 | 1571 | 0.030 |
Why?
|
| Podiatry | 1 | 2016 | 28 | 0.030 |
Why?
|
| Vocal Cords | 1 | 2020 | 522 | 0.030 |
Why?
|
| Hemostasis, Surgical | 2 | 1996 | 126 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2011 | 1496 | 0.030 |
Why?
|
| Duodenal Diseases | 1 | 1996 | 100 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10441 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2002 | 21012 | 0.030 |
Why?
|
| Omentum | 1 | 1996 | 168 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2015 | 516 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 1996 | 218 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 1986 | 3030 | 0.030 |
Why?
|
| Cerebral Angiography | 2 | 2018 | 1281 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2004 | 1212 | 0.030 |
Why?
|
| DNA | 4 | 2000 | 7219 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 3204 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 1995 | 311 | 0.030 |
Why?
|
| Paraplegia | 2 | 2011 | 162 | 0.030 |
Why?
|
| Diagnosis, Differential | 4 | 2010 | 12970 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 1996 | 365 | 0.030 |
Why?
|
| Endothelium | 1 | 1997 | 765 | 0.030 |
Why?
|
| New England | 1 | 2017 | 1053 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 1988 | 2566 | 0.030 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 6485 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2004 | 9179 | 0.030 |
Why?
|
| Organ Preservation Solutions | 1 | 2014 | 100 | 0.030 |
Why?
|
| Mannitol | 1 | 2014 | 180 | 0.030 |
Why?
|
| Disaccharides | 1 | 2014 | 170 | 0.030 |
Why?
|
| Sensitivity and Specificity | 4 | 2004 | 14664 | 0.030 |
Why?
|
| Subclavian Artery | 1 | 2014 | 134 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 2 | 1994 | 1474 | 0.030 |
Why?
|
| Intraoperative Period | 2 | 1995 | 511 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 1995 | 1157 | 0.030 |
Why?
|
| Histidine | 1 | 2014 | 308 | 0.030 |
Why?
|
| Cohort Studies | 6 | 2009 | 41446 | 0.030 |
Why?
|
| Electrolytes | 1 | 2014 | 274 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 1996 | 330 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1995 | 944 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 2015 | 719 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 3122 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1994 | 2561 | 0.030 |
Why?
|
| Upper Extremity | 1 | 2018 | 657 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2013 | 106 | 0.030 |
Why?
|
| Hemodynamics | 3 | 2016 | 4168 | 0.030 |
Why?
|
| Glutamates | 1 | 2014 | 389 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2018 | 1967 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 1999 | 1474 | 0.030 |
Why?
|
| Plethysmography | 1 | 1993 | 175 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2014 | 428 | 0.030 |
Why?
|
| Actins | 1 | 2000 | 2050 | 0.030 |
Why?
|
| Life Tables | 3 | 2000 | 365 | 0.030 |
Why?
|
| Neodymium | 1 | 1992 | 19 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 594 | 0.030 |
Why?
|
| Yttrium | 1 | 1992 | 33 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1998 | 1334 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 695 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2001 | 1458 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 5036 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 1998 | 11073 | 0.030 |
Why?
|
| Prospective Studies | 10 | 2020 | 54415 | 0.030 |
Why?
|
| Half-Life | 1 | 1993 | 652 | 0.020 |
Why?
|
| Hospital Mortality | 2 | 2019 | 5291 | 0.020 |
Why?
|
| Thallium Radioisotopes | 1 | 1992 | 138 | 0.020 |
Why?
|
| Glutathione | 1 | 2014 | 582 | 0.020 |
Why?
|
| Dipyridamole | 1 | 1992 | 140 | 0.020 |
Why?
|
| Risk | 1 | 2004 | 9612 | 0.020 |
Why?
|
| Hypothermia, Induced | 1 | 1997 | 756 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2015 | 674 | 0.020 |
Why?
|
| Paraparesis | 1 | 2011 | 15 | 0.020 |
Why?
|
| Venae Cavae | 1 | 1991 | 41 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2015 | 733 | 0.020 |
Why?
|
| Neutrophils | 1 | 2004 | 3766 | 0.020 |
Why?
|
| Collagen | 1 | 1999 | 2638 | 0.020 |
Why?
|
| Citrates | 1 | 1991 | 135 | 0.020 |
Why?
|
| Citric Acid | 1 | 1991 | 123 | 0.020 |
Why?
|
| Polyethylene Terephthalates | 1 | 1991 | 115 | 0.020 |
Why?
|
| Bioprosthesis | 1 | 1995 | 593 | 0.020 |
Why?
|
| Spectrophotometry | 2 | 1988 | 310 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 4063 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4330 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2014 | 786 | 0.020 |
Why?
|
| Wound Healing | 2 | 2000 | 2803 | 0.020 |
Why?
|
| Medical Records | 1 | 2016 | 1407 | 0.020 |
Why?
|
| DNA Damage | 1 | 2000 | 2446 | 0.020 |
Why?
|
| Ligation | 2 | 2007 | 448 | 0.020 |
Why?
|
| Heart Diseases | 2 | 2018 | 2785 | 0.020 |
Why?
|
| Rabbits | 3 | 1993 | 4779 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 2 | 1985 | 5365 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 2011 | 292 | 0.020 |
Why?
|
| Endoscopes | 1 | 1990 | 168 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 2014 | 609 | 0.020 |
Why?
|
| Ornithine | 2 | 1986 | 79 | 0.020 |
Why?
|
| Comorbidity | 2 | 2014 | 10498 | 0.020 |
Why?
|
| Splanchnic Circulation | 1 | 2009 | 119 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10089 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1997 | 1818 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2013 | 3490 | 0.020 |
Why?
|
| Young Adult | 2 | 2012 | 59207 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2002 | 8000 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 1989 | 573 | 0.020 |
Why?
|
| Motor Activity | 1 | 2018 | 2711 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2013 | 1156 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 1992 | 636 | 0.020 |
Why?
|
| Equipment Design | 2 | 1996 | 3509 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2023 | 3800 | 0.020 |
Why?
|
| Hemoglobin A | 1 | 1988 | 84 | 0.020 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2008 | 36 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2018 | 2977 | 0.020 |
Why?
|
| Evoked Potentials, Motor | 1 | 2011 | 464 | 0.020 |
Why?
|
| Atherectomy | 1 | 2007 | 41 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1991 | 319 | 0.020 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 1988 | 67 | 0.020 |
Why?
|
| Abdomen, Acute | 1 | 2008 | 122 | 0.020 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 1990 | 292 | 0.020 |
Why?
|
| Dogs | 1 | 1992 | 3839 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2017 | 5970 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2002 | 3630 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1989 | 957 | 0.020 |
Why?
|
| Tissue and Organ Procurement | 1 | 2015 | 961 | 0.020 |
Why?
|
| Spermidine | 1 | 1986 | 61 | 0.020 |
Why?
|
| Spermine | 1 | 1986 | 70 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2790 | 0.020 |
Why?
|
| Safety | 1 | 1991 | 1150 | 0.020 |
Why?
|
| Vanadium | 1 | 1986 | 54 | 0.020 |
Why?
|
| Disease Progression | 2 | 2014 | 13502 | 0.020 |
Why?
|
| Thymidine | 1 | 1986 | 299 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2011 | 730 | 0.020 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 1985 | 39 | 0.020 |
Why?
|
| Mitochondria | 1 | 1999 | 3623 | 0.020 |
Why?
|
| Shock, Hemorrhagic | 1 | 2008 | 223 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2011 | 771 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1993 | 2645 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10548 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2005 | 1762 | 0.020 |
Why?
|
| Tibial Arteries | 1 | 2005 | 60 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3580 | 0.020 |
Why?
|
| Administration, Oral | 2 | 1991 | 4016 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 1668 | 0.020 |
Why?
|
| Warfarin | 1 | 1994 | 1483 | 0.020 |
Why?
|
| Shock | 1 | 2008 | 314 | 0.020 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 273 | 0.020 |
Why?
|
| Ulcer | 1 | 2006 | 204 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 1998 | 2491 | 0.020 |
Why?
|
| Aphasia | 1 | 1987 | 192 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2000 | 12796 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 1984 | 5819 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2004 | 36423 | 0.010 |
Why?
|
| Cheek | 1 | 1984 | 65 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1984 | 252 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1996 | 3425 | 0.010 |
Why?
|
| Aneurysm, False | 1 | 2006 | 254 | 0.010 |
Why?
|
| Regeneration | 1 | 2013 | 1511 | 0.010 |
Why?
|
| Shear Strength | 1 | 2004 | 160 | 0.010 |
Why?
|
| Postoperative Care | 2 | 2005 | 1471 | 0.010 |
Why?
|
| Ileum | 1 | 1986 | 557 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2016 | 3905 | 0.010 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1985 | 208 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 2006 | 395 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2005 | 422 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1996 | 2471 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 8999 | 0.010 |
Why?
|
| Body Temperature | 2 | 1997 | 782 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1834 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2013 | 3207 | 0.010 |
Why?
|
| Oxygen | 1 | 2014 | 4228 | 0.010 |
Why?
|
| Anesthesia, Conduction | 1 | 2006 | 262 | 0.010 |
Why?
|
| Aspirin | 1 | 2014 | 3134 | 0.010 |
Why?
|
| Regression Analysis | 4 | 1995 | 6343 | 0.010 |
Why?
|
| Methods | 2 | 1995 | 1074 | 0.010 |
Why?
|
| Myocardium | 1 | 2015 | 4725 | 0.010 |
Why?
|
| Colon | 2 | 1991 | 1792 | 0.010 |
Why?
|
| Bile Duct Neoplasms | 1 | 1988 | 605 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 22163 | 0.010 |
Why?
|
| Creatinine | 2 | 1999 | 1899 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 11902 | 0.010 |
Why?
|
| Linear Models | 1 | 1992 | 5869 | 0.010 |
Why?
|
| Finite Element Analysis | 1 | 2004 | 437 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 1706 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2009 | 2426 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 3879 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5840 | 0.010 |
Why?
|
| Cricetinae | 1 | 1984 | 2425 | 0.010 |
Why?
|
| Telemedicine | 1 | 1998 | 3051 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 2625 | 0.010 |
Why?
|
| Buttocks | 1 | 2000 | 111 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15498 | 0.010 |
Why?
|
| Mice | 5 | 2013 | 81509 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 11458 | 0.010 |
Why?
|
| Pressure Ulcer | 1 | 2000 | 157 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1991 | 10766 | 0.010 |
Why?
|
| Morbidity | 1 | 2004 | 1750 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14409 | 0.010 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 1997 | 38 | 0.010 |
Why?
|
| Sepsis | 1 | 2011 | 2585 | 0.010 |
Why?
|
| Alcoholism | 1 | 2008 | 1973 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5670 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 2000 | 444 | 0.010 |
Why?
|
| Carbohydrate Epimerases | 1 | 1975 | 46 | 0.010 |
Why?
|
| Triose-Phosphate Isomerase | 1 | 1975 | 45 | 0.010 |
Why?
|
| Eflornithine | 2 | 1986 | 31 | 0.010 |
Why?
|
| Thermometers | 1 | 1996 | 42 | 0.010 |
Why?
|
| Epidural Space | 1 | 1997 | 122 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2002 | 2642 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1626 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 1996 | 72 | 0.010 |
Why?
|
| Microcomputers | 1 | 1996 | 141 | 0.010 |
Why?
|
| Fibrinolysis | 1 | 1996 | 332 | 0.010 |
Why?
|
| Pulse | 1 | 1995 | 219 | 0.010 |
Why?
|
| Photography | 1 | 1998 | 532 | 0.010 |
Why?
|
| Compliance | 1 | 1994 | 100 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 826 | 0.010 |
Why?
|
| Infrared Rays | 1 | 1996 | 247 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 2141 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 1997 | 544 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1995 | 335 | 0.010 |
Why?
|
| Pedigree | 2 | 1993 | 4589 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1995 | 461 | 0.010 |
Why?
|
| Pressure | 1 | 1996 | 1155 | 0.010 |
Why?
|
| Elasticity | 1 | 1994 | 655 | 0.010 |
Why?
|
| Feedback | 1 | 1996 | 791 | 0.010 |
Why?
|
| Reference Values | 2 | 1990 | 4921 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 5768 | 0.010 |
Why?
|
| Tensile Strength | 1 | 1992 | 330 | 0.010 |
Why?
|
| Contrast Media | 2 | 1995 | 5311 | 0.010 |
Why?
|
| Anisotropy | 1 | 1994 | 1283 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 1998 | 1121 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2004 | 6238 | 0.010 |
Why?
|
| Gadolinium | 1 | 1995 | 960 | 0.010 |
Why?
|
| Sutures | 1 | 1992 | 284 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1990 | 170 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 2228 | 0.010 |
Why?
|
| Peritoneum | 1 | 1990 | 225 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1986 | 11526 | 0.000 |
Why?
|
| Absorption | 1 | 1988 | 243 | 0.000 |
Why?
|
| Blood Pressure | 1 | 2004 | 8487 | 0.000 |
Why?
|
| Cystic Duct | 1 | 1988 | 18 | 0.000 |
Why?
|
| Hepatic Duct, Common | 1 | 1988 | 48 | 0.000 |
Why?
|
| Rest | 1 | 1993 | 919 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1985 | 4248 | 0.000 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1988 | 120 | 0.000 |
Why?
|
| Critical Care | 1 | 2000 | 2697 | 0.000 |
Why?
|
| Feasibility Studies | 1 | 1998 | 5246 | 0.000 |
Why?
|
| Sheep | 1 | 1990 | 1440 | 0.000 |
Why?
|
| 1,2-Dimethylhydrazine | 1 | 1986 | 8 | 0.000 |
Why?
|
| Dimethylhydrazines | 1 | 1986 | 12 | 0.000 |
Why?
|
| Cocarcinogenesis | 1 | 1986 | 49 | 0.000 |
Why?
|
| Respiration Disorders | 1 | 1990 | 367 | 0.000 |
Why?
|
| RNA | 2 | 1986 | 2723 | 0.000 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1988 | 506 | 0.000 |
Why?
|
| Pain | 1 | 2000 | 5071 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1994 | 2242 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1988 | 1540 | 0.000 |
Why?
|
| Exercise Test | 1 | 1992 | 2129 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1994 | 1923 | 0.000 |
Why?
|
| Colonoscopy | 1 | 1991 | 1394 | 0.000 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1985 | 507 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1985 | 13637 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1986 | 1414 | 0.000 |
Why?
|
| Adaptation, Physiological | 1 | 1986 | 1301 | 0.000 |
Why?
|
| Emergencies | 1 | 1985 | 1217 | 0.000 |
Why?
|
| Smoking | 1 | 1994 | 9052 | 0.000 |
Why?
|
| Hydroxymercuribenzoates | 1 | 1975 | 4 | 0.000 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 1975 | 20 | 0.000 |
Why?
|
| Aging | 1 | 1994 | 8705 | 0.000 |
Why?
|
| Body Weight | 1 | 1986 | 4618 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1975 | 2498 | 0.000 |
Why?
|
| Muscles | 1 | 1975 | 1576 | 0.000 |
Why?
|
| Kinetics | 1 | 1975 | 6374 | 0.000 |
Why?
|
| Binding Sites | 1 | 1975 | 6055 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1975 | 2687 | 0.000 |
Why?
|
| Protein Binding | 1 | 1975 | 9352 | 0.000 |
Why?
|
| Adolescent | 1 | 1988 | 88313 | 0.000 |
Why?
|